Παρασκευή 31 Μαρτίου 2017

Combined modality therapy improves overall survival for angiosarcoma.

Combined modality therapy improves overall survival for angiosarcoma.

Acta Oncol. 2017 Mar 30;:1-4

Authors: Shen CJ, Parzuchowski AS, Kummerlowe MN, Morris CD, Meyer CF, Habibi M, Frassica DA, Levin AS, Thornton KA, Terezakis SA

PMID: 28358642 [PubMed - as supplied by publisher]



http://ift.tt/2nGSblW

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου